ORBIMED ADVISORS LLC Q4 2017 Filing

Filed February 14, 2018

Portfolio Value

$7.9T

Holdings

130

Report Date

Q4 2017

Filing Type

13F-HR

All Holdings (130 positions)

#StockSharesValue% PortfolioType
101
AMEDAMEDISYS INC
207,500$10.9B0.14%
102
NOVUS THERAPEUTICS INC
2,537,110$10.3B0.13%
103
FLBFLUIDIGM CORP DEL
1,583,700$9.3B0.12%
104
BMRNBIOMARIN PHARMACEUTICAL INC
100,600$9.0B0.11%
105
SRPTSAREPTA THERAPEUTICS INC
149,400$8.3B0.11%Call
106
LAB 2.75 02/01/34FLUIDIGM CORP DEL
10,000,000$8.3B0.11%
107
KIDSORTHOPEDIATRICS CORP
425,200$8.2B0.10%
108
AUPHAURINIA PHARMACEUTICALS INC
1,797,400$8.1B0.10%
109
AGLEUSDAEGLEA BIOTHERAPEUTICS INC
1,469,524$8.0B0.10%
110
ENDO INTL PLC
1,024,386$7.9B0.10%
111
ALKSALKERMES PLC
145,000$7.9B0.10%
112
INOTEK PHARMACEUTICALS CORP
7,000,000$5.9B0.07%
113
GW PHARMACEUTICALS PLC
44,400$5.9B0.07%
114
TESARO INC
67,281$5.6B0.07%
115
MARINUS PHARMACEUTICALS INC
567,600$4.6B0.06%
116
PRQRPROQR THRAPEUTICS N V
1,302,955$4.2B0.05%
117
SNDXSYNDAX PHARMACEUTICALS INC
437,000$3.8B0.05%
118
RDHLGBPREDHILL BIOPHARMA LTD
564,900$2.9B0.04%
119
MCRB1EURSERES THERAPEUTICS INC
219,458$2.2B0.03%
120
XENEXENON PHARMACEUTICALS INC
634,812$1.8B0.02%
121
OREXIGEN THERAPEUTICS INC
5,210,000$1.8B0.02%
122
BHCVALEANT PHARMACEUTICALS INTL
76,800$1.6B0.02%
123
BIOLINERX LTD
1,038,600$1.1B0.01%
124
BIOMARIN PHARMACEUTICAL INC
500,000$594.0M0.01%
125
BIOMARIN PHARMACEUTICAL INC
500,000$540.0M0.01%
126
AFFIMED N V
326,650$425.0M0.01%
127
ALIMERA SCIENCES INC
250,000$333.0M0.00%
128
NOVELION THERAPEUTICS INC
100,000$312.0M0.00%
129
XTANT MED HLDGS INC
4,754,386$272.0M0.00%
130
MEDIGUS LTD
60,000$79.0M0.00%
PreviousPage 2 of 2